134 related articles for article (PubMed ID: 2049682)
1. Designing clinical trials in the post CAST era--where do we go from here?
Dorian P
Can J Cardiol; 1991 Mar; 7(2):105-7; discussion 110-2. PubMed ID: 2049682
[No Abstract] [Full Text] [Related]
2. Evaluation of antiarrhythmic drugs by sudden death trials.
Fisher LD
Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
[No Abstract] [Full Text] [Related]
3. [Cardiac arrhythmia suppression trial (CAST)].
Furlanello F
G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
[No Abstract] [Full Text] [Related]
4. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
Camm AJ; Kautzner J
Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
[TBL] [Abstract][Full Text] [Related]
5. [Antiarrhythmic agents: current situation].
Bonhorst D
Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
Gambhir DS
Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
[No Abstract] [Full Text] [Related]
7. [Anti-arrhythmia agents and sudden death].
Correia MJ
Rev Port Cardiol; 1992 Apr; 11(4):391-6. PubMed ID: 1632997
[No Abstract] [Full Text] [Related]
8. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
Arós Borau F; Loma-Osorio A; Torres Bosco A
Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
[TBL] [Abstract][Full Text] [Related]
9. Prevention of sudden cardiac death: lessons from the cardiac arrhythmia suppression trial (CAST).
Schlant RC
J Med Assoc Ga; 1990 Apr; 79(4):245-7. PubMed ID: 2185327
[No Abstract] [Full Text] [Related]
10. [Therapy of arrhythmias in hypertrophic cardiomyopathy].
Rapezzi C; Spirito P
G Ital Cardiol; 1995 Nov; 25(11):1443-6. PubMed ID: 8682242
[No Abstract] [Full Text] [Related]
11. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
Magalhães CO
Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
[No Abstract] [Full Text] [Related]
12. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
Candinas R; Bauersfeld U
Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
[TBL] [Abstract][Full Text] [Related]
13. [Symposium: Sudden cardiac death. The importance of amiodarone in the treatment of life-threatening arrhythmia. Munich, 10-11 June 1988].
Internist (Berl); 1988 Aug; 29(8 Suppl):1-16. PubMed ID: 3058623
[No Abstract] [Full Text] [Related]
14. Clinical efficacy of amiodarone.
Nolan PE; Nappi J; Pollak PT
Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
[TBL] [Abstract][Full Text] [Related]
15. Long term management of ventricular arrhythmias--to treat or not to treat?
Talajic M
Can J Cardiol; 1991 Mar; 7(2):96-7; discussion 103-4. PubMed ID: 2049689
[No Abstract] [Full Text] [Related]
16. Management of cardiac arrest survivors: drugs or devices.
Madan N; Saksena S; Prakash A; Mathew PP
Indian Heart J; 1995; 47(4):387-93. PubMed ID: 8557286
[No Abstract] [Full Text] [Related]
17. Dronedarone: NICE enough?
Khoo CW; Lim HS; Lip GY
Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1049-51. PubMed ID: 20670181
[No Abstract] [Full Text] [Related]
18. Problems in design and evaluation of antiarrhythmia trials.
Prineas RJ
Circulation; 1975 Dec; 52(6 Suppl):III248-57. PubMed ID: 1102146
[No Abstract] [Full Text] [Related]
19. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
Naccarella F; Croci F
G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
[No Abstract] [Full Text] [Related]
20. Amiodarone and mortality in CHF and post-MI.
Zamorski M
J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
